Related Experiment Video
Updated: Apr 5, 2026

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs
Published on: August 15, 2025
F-box protein 7 mutations promote protein aggregation in mitochondria and inhibit mitophagy
Zhi Dong Zhou1, Shao Ping Xie2, Sushmitha Sathiyamoorthy2
1National Neuroscience Institute of Singapore, 11 Jalan Tan Tock Seng, Singapore, Singapore, Signature Research Program in Neuroscience and Behavioral Disorders, Duke-NUS Graduate Medical School Singapore, 8 College Road, Singapore, Singapore.
Abstract:
The mutations of F-box protein 7 (FBXO7) gene (T22M, R378G and R498X) are associated with a severe form of autosomal recessive juvenile-onset Parkinson's disease (PD) (PARK 15). Here we demonstrated that wild-type (WT) FBXO7 is a stress response protein and it can play both cytoprotective and neurotoxic roles. The WT FBXO7 protein is vital to cell mitophagy and can facilitate mitophagy to protect cells, whereas mutant FBXO7 inhibits mitophagy. Upon stress, the endogenous WT FBXO7 gets up-regulated, concentrates into mitochondria and forms FBXO7 aggregates in mitochondria. However, FBXO7 mutations aggravate deleterious FBXO7 aggregation in mitochondria. The FBXO7 aggregation and toxicity can be alleviated by Proline, glutathione (GSH) and coenzyme Q10, whereas deleterious FBXO7 aggregation in mitochondria can be aggravated by prohibitin 1 (PHB1), a mitochondrial protease inhibitor. The overexpression of WT FBXO7 could lead to FBXO7 protein aggregation and dopamine neuron degeneration in transgenic Drosophila heads. The elevated FBXO7 expression and aggregation were identified in human fibroblast cells from PD patients. FBXO7 can also form aggregates in brains of PD and Alzheimer's disease. Our study provides novel pathophysiologic insights and suggests that FBXO7 may be a potential therapeutic target in FBXO7-linked neuron degeneration in PD.
Insights
Mutant F-box protein 7 (FBXO7) inhibits mitophagy, causing cell damage linked to Parkinson's disease. Therapies targeting FBXO7 aggregation show potential for treating neurodegenerative disorders.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Mutations in the F-box protein 7 (FBXO7) gene are linked to autosomal recessive juvenile-onset Parkinson's disease (PARK 15).
- Wild-type (WT) FBXO7 functions as a stress response protein with dual cytoprotective and neurotoxic roles.
Purpose of the Study:
- To investigate the role of WT and mutant FBXO7 in cellular stress response and mitophagy.
- To explore the impact of FBXO7 aggregation on neurodegeneration in Parkinson's disease (PD) and Alzheimer's disease (AD).
Main Methods:
- Examined FBXO7 localization and aggregation in mitochondria under stress conditions.
- Assessed the effects of various compounds (Proline, GSH, CoQ10, PHB1) on FBXO7 aggregation.
- Utilized transgenic Drosophila models and human fibroblast cells from PD patients to study FBXO7's in vivo effects.
Main Results:
- WT FBXO7 facilitates mitophagy for cell protection, while mutant FBXO7 inhibits it.
- FBXO7 mutations exacerbate deleterious mitochondrial aggregation under stress.
- Overexpression of WT FBXO7 can induce protein aggregation and dopamine neuron degeneration.
- Elevated FBXO7 expression and aggregation are observed in PD patient cells and in the brains of PD and AD patients.
Conclusions:
- FBXO7 plays a critical role in mitophagy and cellular response to stress.
- FBXO7 aggregation is a key pathological feature in FBXO7-linked neurodegeneration.
- FBXO7 represents a potential therapeutic target for PD and other neurodegenerative diseases involving FBXO7 dysfunction.
More Related Videos
Related Concept Videos
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Mitochondrial Protein Sorting
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Mitochondrial Precursor Proteins
Most of the mitochondrial...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
The Intrinsic Apoptotic Pathway

